CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,722,203
-$3,769,696 QoQ
Shares Held
703,552
-0.3% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. SUPN ranks #13 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,722,203 | 703,552 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,491,899 | 705,976 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,970,162 | 703,625 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,005,649 | 732,489 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $23,597,164 | 748,641 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $24,436,379 | 746,149 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $27,241,606 | 753,363 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $22,212,476 | 712,395 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $16,612,846 | 621,041 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $20,215,155 | 592,646 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $16,088,614 | 555,930 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $14,646,452 | 531,246 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $16,307,790 | 542,508 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $18,470,271 | 509,806 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,100,777 | 507,451 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,834,149 | 467,774 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,419,722 | 429,451 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,002,012 | 402,290 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,762,722 | 369,092 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,654,673 | 362,005 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $12,886,846 | 418,540 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,805,321 | 450,929 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,057,744 | 439,497 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,309,519 | 446,714 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,148,197 | 343,082 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $5,759,390 | 320,144 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||